Cat.#: ACPP-1340
| Despition | PDE7A Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1656 | Human MAPT Protein (AC1656) | 2 µg | inquiry |
| ACPP-1493 | Human Thyroid Stimulating Hormone Receptor (Active) Protein (AC1493) | 1 mg | inquiry |
| ACPP-1454 | Human PICK1 Protein (AC1454) | 2 µg | inquiry |
| ACPP-1617 | Human PARK2 Protein (AC1617) | 5 µg | inquiry |
| ACPP-1164 | Synthetic Nanodisc Human GRPR Protein (AC1164) | 10 µg | inquiry |
| ACPP-1343 | GIRK1 Blocking Peptide (AC1343) | 250 µg | inquiry |
| ACPP-1393 | Human ALDH3A1 Protein (AC1393) | 2 µg | inquiry |
| ACPP-1178 | Recombinant Human CXCR4 Protein (Fc Tag) (AC1178) | 50 µg | inquiry |
| ACPP-1529 | Human KCTD4 Protein (AC1529) | 2 µg | inquiry |
| ACPP-1542 | Human GSK3B Protein , sf9 (AC1542) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.